Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities
Clive Ballard(University of Exeter), Robert Barber(University of North Texas), Robert Howard(University College London), Katharina Reichelt(Newcastle University), Dawn Potkins(North Tyneside General Hospital), Jay Shrimanker(North Tyneside General Hospital), Pat Myint(North Tyneside General Hospital), Ian Powell(North Tyneside General Hospital), Ian James(Cumbria Northumberland Tyne and Wear NHS Foundation Trust), Carol Bannister(Warneford Hospital), Marisa Lana(Bensham Hospital), John T. O’Brien(North Tyneside General Hospital), Alan Swann(North Tyneside General Hospital), Damian Robinson(North Tyneside General Hospital)
Cited by 64
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Cognitive decline in Parkinson disease
|Nature Reviews Neurology|2017|994